FDA Inspection 1321522 — Innovative Blood Resources

Innovative Blood Resources — FEI 3003294594

The FDA completed an inspection of Innovative Blood Resources on June 3, 2026 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 3, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lincoln, NE (United States)